Daicel Corporation (TYO:4202)

Market Cap	373.56B
Revenue (ttm)	580.23B
Net Income (ttm)	42.91B
Shares Out	265.13M
EPS (ttm)	158.91
PE Ratio	8.87
Forward PE	7.06
Dividend	60.00 (4.26%)
Ex-Dividend Date	Sep 29, 2025

Volume	787,800
Average Volume	600,510
Open	1,405.00
Previous Close	1,405.00
Day's Range	1,398.50 - 1,410.50
52-Week Range	1,057.50 - 1,482.00
Beta	0.20
RSI	60.30
Earnings Date	Nov 6, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1919
• Employees: 11,178
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4202

Financial Performance

In 2024, Daicel's revenue was 586.53 billion, an increase of 5.10% compared to the previous year's 558.06 billion. Earnings were 49.48 billion, a decrease of -11.38%.